Alphapolyomavirus quintihominis Large T antigen 95-103, RSGGFSFGK
Description
About Alphapolyomavirus quintihominis Large T antigen 95-103, RSGGFSFGK
The Alphapolyomavirus quintihominis Large T antigen Peptide (IEDB: 1310189) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Large T antigen Peptide, H-RSGGFSFGK-OH (Uniprot: B6DVW7 aa: 95-103) from JPT is produced under strict quality control and quality management.
Alphapolyomavirus quintihominis Large T antigen 95-103, RSGGFSFGK - Specifications
- Peptide sequence: H-RSGGFSFGK-OH
- Amount: 1 mg
- Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
- Counterion: TFA
- Delivery Format: Freeze-dried in glass vial
- Application(s): T-cell Immunity
- Condition(s)/Topic(s): Infection
- Standard Delivery Time: approx. 3 weeks
JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!
Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!
References
References for Alphapolyomavirus quintihominis Large T antigen 95-103, RSGGFSFGK
Read References with JPT’s Antigen Peptides
Alphapolyomavirus quintihominis Large T antigen 95-103, RSGGFSFGK has been described in:
The high prevalence and diverse HLA restriction of intratumoral viral oncoprotein-specific CD8 T cells support active vaccination as a possible therapeutic modality for polyoma virus-driven Merkel cell carcinoma, nan, 2019
Prevalent and Diverse Intratumoral Oncoprotein-Specific CD8+ T Cells within Polyomavirus-Driven Merkel Cell Carcinomas., Cancer Immunol Res, 2020 (PMID: 32179557)
Documentation
Documentation for Alphapolyomavirus quintihominis Large T antigen 95-103, RSGGFSFGK
Properties
Properties of Alphapolyomavirus quintihominis Large T antigen 95-103, RSGGFSFGK
Properties | Values |
---|---|
Application: | T-cell immunity |
Category: | Antigen Peptides |
Condition / Topic: | Infection |
Layout: | Freeze-dried in glass vial |
Organism: | Alphapolyomavirus quintihominis |
Protein Name: | Large T antigen |
Purity: | Trial Grade: each peptide purified to > 90% (HPLC/MS) |
Quantification: | No, Yes |
Further Information to Alphapolyomavirus quintihominis Large T antigen 95-103, RSGGFSFGK
Information | Values |
---|---|
Sequence: | H-RSGGFSFGK-OH |
Specifications: | 9mer peptide as TFA salt |